NOTIFICATION
Addendum
The following communication, dated 21
November 2024, is being circulated at the request of the delegation of Brazil.
_______________
Title: Draft
Resolution number 760
Description: Resolution 742, 10 August 2022 -
previously notified through G/TBT/N/BRA/955/Add.1 - which establishes the
minimal technical requirements for relative bioavailability and bioequivalence
studies that supports dossier of consent for clinical research, market
authorization or post-market authorization of medicines, in the terms of this
resolution, was changed by Resolution 942, 18 November 2024.
The final text is available only in Portuguese and can be
downloaded at:
https://antigo.anvisa.gov.br/documents/10181/3855414/RDC_942_2024_.pdf/bf46fb32-1ddb-4ba9-abf4-e6fac15966e2
__________
[1] This information can be provided by including a website address, a
pdf attachment, or other information on where the text of the final/modified
measure and/or interpretive guidance can be obtained.